Genetic signature of human longevity in PKC and NF-κB signaling

Seungjin Ryu, Jeehae Han, Trina M. Norden-Krichmar, Quanwei Zhang, Seunggeun Lee, Zhengdong Zhang, Gil Atzmon, Laura J. Niedernhofer, Paul D. Robbins, Nir Barzilai, Nicholas J. Schork, Yousin Suh

Research output: Contribution to journalArticlepeer-review


Gene variants associated with longevity are also associated with protection against cognitive decline, dementia and Alzheimer's disease, suggesting that common physiologic pathways act at the interface of longevity and cognitive function. To test the hypothesis that variants in genes implicated in cognitive function may promote exceptional longevity, we performed a comprehensive 3-stage study to identify functional longevity-associated variants in ~700 candidate genes in up to 450 centenarians and 500 controls by target capture sequencing analysis. We found an enrichment of longevity-associated genes in the nPKC and NF-κB signaling pathways by gene-based association analyses. Functional analysis of the top three gene variants (NFKBIA, CLU, PRKCH) suggests that non-coding variants modulate the expression of cognate genes, thereby reducing signaling through the nPKC and NF-κB. This matches genetic studies in multiple model organisms, suggesting that the evolutionary conservation of reduced PKC and NF-κB signaling pathways in exceptional longevity may include humans.

Original languageEnglish
Article numbere13362
Pages (from-to)e13362
JournalAging Cell
Issue number7
StatePublished - Jul 2021

Bibliographical note

© 2021 The Authors. Aging Cell published by Anatomical Society and John Wiley & Sons Ltd.


  • NF-kappa B
  • PKC
  • centenarian
  • genetic variant
  • longevity
  • rare variant


Dive into the research topics of 'Genetic signature of human longevity in PKC and NF-κB signaling'. Together they form a unique fingerprint.

Cite this